Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy
22h ago· 1 min readNews
Source
bskyMethylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapydoi.orgMethylation-based ctDNA monitoring in 57 patients closely reflects outcomes in ER+, HER2- metastatic breast cancer during CDK4/6 inhibitor therapy, signaling a new era in treatment surveillance. PMID:42243127, Nat Commun 2026, @NatureComms #Medsky #RNA 🧪
You might also wanna read
Breast Cancer Treatment Strategies: AI ± CDK4/6 Inhibitors, Biomarkers, and ESR1 Mutations
This article appears to be a medical education piece focused on breast cancer treatment strategies, specifically discussing patients progres
mdsc.pe·14d ago
Meta-analysis of DNA methylation aging signatures in 17 human tissues
nature.com·4d ago
Ask HN: What is the latest on treatment of Metastatic Breast Cancer?
news.ycombinator.com·1y ago
Nicola Fusco: CtDNA Interpretation in HR+/HER2- Metastatic Breast Cancer
OncoDaily·1h ago
The case for and against universal newborn DNA sequencing
A brief article about Freddie, a baby diagnosed with retinoblastoma (eye cancer) at four weeks old, who was successfully treated with chemot
The Economist·8d agoThe case for and against universal newborn DNA sequencing
A brief article about Freddie, a baby diagnosed with retinoblastoma (eye cancer) at four weeks old, who was successfully treated with chemot
economist.com·8d ago
Estudo vê economia com teste genômico no câncer de mama
Extra Online·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.